...
首页> 外文期刊>Journal of Clinical Oncology >Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
【24h】

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.

机译:局限性前列腺癌根治性前列腺切除术后术后诺模图准确性的验证研究。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: A postoperative nomogram for prostate cancer was developed at Baylor College of Medicine. This nomogram uses readily available clinical and pathologic variables to predict 7-year freedom from recurrence after radical prostatectomy. We evaluated the predictive accuracy of the nomogram when applied to patients of four international institutions. PATIENTS AND METHODS: Clinical and pathologic data of 2,908 patients were supplied for validation, and 2,465 complete records were used. Nomogram-predicted probabilities of 7-year freedom from recurrence were compared with actual follow-up in two ways. First, the area under the receiver operating characteristic curve (AUC) was calculated for all patients and stratified by the time period of surgery. Second, calibration of the nomogram was achieved by comparing the predicted freedom from recurrence with that of an ideal nomogram. For patients in whom the pathologic report does not distinguish between focal and established extracapsular extension (an input variable of the nomogram), two separate calculations were performed assuming one or the other. RESULTS: The overall AUC was 0.80 when applied to the validation data set, with individual institution AUCs ranging from 0.77 to 0.82. The predictive accuracy of the nomogram was apparently higher in patients who were operated on between 1997 and 2000 (AUC, 0.83) compared with those treated between 1987 and 1996 (AUC, 0.78). Nomogram predictions of 7-year freedom from recurrence were within 10% of an ideal nomogram. CONCLUSION: The postoperative Baylor nomogram was accurate when applied at international treatment institutions. Our results suggest that accurate predictions may be expected when using this nomogram across different patient populations.
机译:目的:在贝勒医学院开发了前列腺癌的术后诺模图。该诺模图使用现成的临床和病理变量来预测前列腺癌根治术后术后7年无复发。我们评估了将诺模图应用于四个国际机构的患者时的预测准确性。患者和方法:提供了2908例患者的临床和病理学数据进行验证,并使用了2465例完整记录。用线照相术预测的7年无复发的可能性通过两种方式与实际随访进行了比较。首先,计算所有患者的接受者工作特征曲线(AUC)下的面积,并按手术时间分层。其次,通过比较预测的递归自由度与理想列线图的自由度来实现列线图的校准。对于病理报告无法区分局灶性和已确定的囊外扩张(列线图的输入变量)的患者,假设一个或另一个进行两次单独的计算。结果:应用于验证数据集的总体AUC为0.80,单个机构的AUC在0.77至0.82之间。与1987年至1996年间接受治疗的患者(AUC,0.78)相比,1997年至2000年接受手术的患者(AUC,0.83)的诺模图预测准确性明显更高。对复发的7年自由度的线照相术预测在理想线照相术的10%以内。结论:在国际治疗机构中使用术后贝勒诺模图是准确的。我们的结果表明,在不同患者人群中使用该诺模图时,可以期望得到准确的预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号